← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Synergys Biotherapeutics, Inc.
Alamo, CA
$1,000,000
Total funding
3
Grants
Funding over time
peak $400K · FY2017–22$500K$375K$250K$125K$0
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$1,000,000 · 3
By mechanism
R43$600,000 · 2
R44$400,000 · 1
Investigators at Synergys Biotherapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Development of Anti-EGFR-huEndo-P125A: A combined Vasculogenic Mimicry-Angiogenesis inhibitory therapeutic for Triple Negative Breast Cancer$400,000
R44 · FY2022 · CA
Targeting angiogenesis and vasculogenic mimicry in Triple Negative Breast Cancer$300,000
R43 · FY2017 · CA
Combined Inhibition of Vasculogenic Mimicry and Angiogenesis in Ovarian Cancer using Antibody Fusion Protein$300,000
R43 · FY2019 · CA